ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Induction therapy"

  • 2020 American Transplant Congress

    Short Term Outcomes in Kidney Transplant Patients Receiving De Novo Belatacept with Anti-Thymocyte Globulin Induction

    B. Carlson, P. Cabrera, T. Harrison, K. Tejani, A. Centeno

    Pharmacy, Jackson Memorial Hospital, Miami, FL

    *Purpose: Mainstay immunosuppressive therapy after kidney transplant is a calcineurin inhibitor (CNI) based regimen. Nephrotoxicity is a common adverse effect of CNIs which can lead…
  • 2020 American Transplant Congress

    Peri-Operative Extracorporeal Photopheresis in High Risk Patients after Heart Transplantation

    A. Zuckermann1, J. Gökler1, N. Worel2, P. Angleitner1, E. Ceran1, E. Ceran1, N. Neuber1, P. Kaiser1, G. Laufer1, A. Aliabadi-Zuckermann1

    1Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria, 2Department of Transfusion Medicine, Medical University of Vienna, Vienna, Austria

    *Purpose: Extracorporeal photopheresis (ECP) is an established therapy for treatment of heart transplant rejection and is also applied for rejection prevention in the perioperative setting…
  • 2020 American Transplant Congress

    Anti-HLA IgM Antibodies are Unaffected by Imlifidase (IdeS) Treatment

    A. Runström1, R. Bockermann1, K. Sjöholm1, K. M. Roupé1, Å. Schiött1, L. Winstedt1, C. Kjellman1, T. Lorant2

    1Hansa Biopharma AB, Lund, Sweden, 2Section of Transplantation Surgery, Department of Surgical Sciences, Uppsala, Sweden

    *Purpose: The immunoglobulin G (IgG)-degrading cysteine protease, imlifidase (IdeS) is an IgG endopeptidase under development as a rapid desensitization treatment in kidney transplantation. Imlifidase is…
  • 2020 American Transplant Congress

    Outcomes of Induction with T Lymphocyte-Depleting and IL-2 Receptor Blocking (IL-2RB) Antibodies in the Non-Broadly Sensitized Adult Deceased-Donor Kidney Transplant Recipients: Analysis in the Context of the CPRA Allocation System

    A. H. Santos Jr1, Y. Li2, K. Alquadan1, M. Leghrouz1, X. Wen3

    1Div. of Nephrology, Univ. of Florida, Gainesville, FL, 2Univ. of Florida, Gainesville, FL, 3Univ. of Rhode Island, Kingston, RI

    *Purpose: We studied outcomes of induction in non-broadly-sensitized adult deceased-donor kidney transplant recipients(DD-KTRs) in the context of the calculated panel reactive antibody (CPRA) allocation system.*Methods:…
  • 2020 American Transplant Congress

    Comparison of Short-Term Outcomes of Induction Therapy with Alemtuzumab versus Rabbit Antithymocyte Globulin in Lung Transplantation

    V. Liu, M. W. Soto-Arenall, A. Patel

    Pharmacy, Mayo Clinic, Jacksonville, FL

    *Purpose: To identify the short-term efficacy and safety outcomes of alemtuzumab (C1H) versus rabbit antithymocyte globulin (rATG) in lung transplant patients. The objectives are to…
  • 2020 American Transplant Congress

    Induction Immunosuppression in Primary Pediatric Liver Transplant Recipients

    T. Shaker1, K. Ramanathan1, S. Riad2, D. Vock3, S. Chinnakotla1

    1Surgery, Division of Transplantation, University of Minnesota, Minneapolis, MN, 2Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, 3Biostatistics, University of Minnesota, Minneapolis, MN

    *Purpose: Induction immunosuppression for pediatric liver transplants varies widely among centers. We sought to evaluate the impact of different induction regimens on patient and graft…
  • 2020 American Transplant Congress

    Outcomes of Intra-Operative Steroid Induction in Liver Transplant Recipients

    A. Poparad-Stezar, A. Jantz, T. Larson, B. Summers, N. Sulejmani

    Henry Ford Hospital, Detroit, MI

    *Purpose: Evidence supporting the use of antibody induction (AI) immunosuppression (IS) (antithymocyteglobulin (rATG) and basiliximab (BAS)) for acute rejection (AR) prophylaxis in liver transplant is…
  • 2020 American Transplant Congress

    Depletional Profiles of Human and Rhesus Specific Anti-Thymocyte Globulins in Rhesus Macaques

    B. I. Shaw1, R. Schmitz1, D. M. Magnani2, F. Leopardi1, A. D. Kirk1

    1Surgery, Duke University, Durham, NC, 2Medicine, MassBiologics of the University of Massachusetts Medical School, Boston, MA

    *Purpose: Rabbit anti-human ATG (rATG; Thymoglobulin®) is the most commonly used formulation for depletional induction therapy in the United States. However, given that it is…
  • 2019 American Transplant Congress

    Impact of Induction Choice and Early Steroid Withdrawal on Outcomes in HLA Zero Mismatched Kidney Transplant Recipients

    C. Votruba1, K. Holdener1, B. Astor2, F. Aziz2, D. Mandelbrot2

    1Pharmacy, University of Wisconsin Hospitals and Clinics, Madison, WI, 2Nephrology, University of Wisconsin Hospitals and Clinics, Madison, WI

    *Purpose: Ideal induction and immunosuppression therapy for 6-antigen HLA matched deceased and living kidney transplant recipients (KTR) is not well understood.*Methods: All 6-antigen HLA matched…
  • 2019 American Transplant Congress

    Low Dose Anti-Thymocyte Globulin is Enough to Prevent Acute Cellular Rejection in Kidney Transplant

    P. W. Baron1, J. Weissman2, F. Fazeli3, C. Zuppan4, R. Villicana3, P. Wai1, L. Beeson5, M. De Vera1

    1Surgery/Transplantation Institute, Loma Linda University Health, Loma Linda, CA, 2Pharmacy, Loma Linda University Health, Loma Linda, CA, 3Transplantation Institute, Loma Linda University Health, Loma Linda, CA, 4Pathology, Loma Linda University Health, Loma Linda, CA, 5Center for Nutrition, Healthy Lifestyle and Disease Prevention/School of Public Health, Loma Linda University Health, Loma Linda, CA

    *Purpose: Rabbit anti-thymocyte globulin (rATG) cumulative dose needed to effectively and safely prevent acute cellular rejection is unknown. This study compares the efficacy of total…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 31
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences